4CMenB (Bexsero)

Meningococcal B vaccine, four-component (4CMenB) · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 4CMenB (Bexsero), covering 2024-11-05 to 2024-11-05. Get the full timeline:

Most recent: Clinical Trial Update: Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination [Phase 2]